Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer

We ascertained 184 Ashkenazi Jewish women with breast/ovarian cancer (171 breast and 13 ovarian cancers, two of the former also had ovarian cancer) in a self-referral study. They were tested for germline founder mutations in BRCA1 (185delAG, 5382insC, 188del11) and BRCA2 (6174delT). Personal/family...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hodgson, S., Heap, E., Cameron, J., Ellis, D., Mathew, C., Eeles, R., Solomon, E., Lewis, C.
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 1999
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1734368/
https://ncbi.nlm.nih.gov/pubmed/10353781
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky